Hereditary Cancer Panel — Genetic Risk Test
£599.99
£499.99
Find out if you carry inherited genetic mutations that significantly increase cancer risk. Tests 30+ genes including BRCA1, BRCA2, and Lynch syndrome markers. From a simple saliva sample.
- ✓ Free UK Shipping
- ✓ Results in 3–4 Weeks
- ✓ 30+ High-Risk Genes Tested
- ✓ Clinical-Grade Sequencing
Personal History of Cancer (optional)
Family History of Cancer (optional)
Key Features
-
What the Hereditary Cancer Panel Tests
Around 5–10% of cancers are caused by inherited genetic mutations passed down through families. The Hereditary Cancer Panel analyses 30+ genes known to significantly increase the risk of developing certain cancers, including:
- Breast and ovarian cancer (BRCA1, BRCA2, PALB2)
- Bowel cancer and Lynch syndrome (MLH1, MSH2, MSH6, PMS2)
- Prostate, pancreatic, and gastric cancers
- Rare hereditary cancer syndromes (Li-Fraumeni, Cowden, FAP)
-
Who Should Take This Test
- Anyone with a strong family history of cancer (multiple relatives, early-onset cases)
- Those of Ashkenazi Jewish heritage (higher BRCA mutation rates)
- Anyone diagnosed with cancer who wants to understand inherited risk for relatives
- People making informed decisions about screening, preventive surgery, or family planning
-
Will my GP accept these results?
Yes. The test is processed in a clinical-grade laboratory and the report is suitable for sharing with your GP or a specialist.
Does this test ancestry or paternity?
No. This is a clinical cancer-risk test only. It does not provide ancestry, paternity, or general health-trait information.
Important Note
This is a clinical-grade genetic test with significant implications. Before ordering, we strongly recommend you read our guide on hereditary cancer testing or speak to a genetic counsellor. A positive result can affect insurance applications and emotional wellbeing — this is information that, once known, cannot be unknown.
How It Works
1. Order & Receive
Free UK delivery within 2 working days. Saliva collection kit included.
2. Provide Your Sample
Simple saliva sample. No blood, no needles. Takes 2 minutes.
3. Receive Your Report
Comprehensive genetic report in your secure account within 3–4 weeks, with explanation of any findings.
Product FAQ
If I have a positive result, does it mean I will get cancer?
No. A positive result means you have an increased risk, not certainty. Many people with high-risk mutations never develop cancer. The result helps you make informed decisions about screening and prevention.
Will this affect my life insurance?
In the UK, insurers cannot ask about most predictive genetic test results under the current Code on Genetic Testing and Insurance (with limited exceptions for very high-value policies). However, the rules can change. We strongly recommend reviewing the latest guidance before testing if insurance is a concern.
Should I speak to a genetic counsellor first?
Yes, we strongly recommend it. Genetic test results carry emotional and family implications. Our team can guide you to NHS or private counselling services.
Biomarkers checked
| Comprehensive Hereditary Cancer Panel | APC, ATM1, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK22, EPCAM3, HOXB13, MLH1, MSH2, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS24, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53, VHL |
| Hereditary Breast Cancer Panel | ATM1, BARD1, BRCA1, BRCA2, CHEK22, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53 |
| Hereditary Breast and Gynaecological Cancer Panel | ATM1, BARD1, BRCA1, BRCA2, BRIP1, CHEK22, EPCAM3, MLH1, MSH2, MSH6, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53 |
| Hereditary Prostate Cancer | ATM1, BRCA1, BRCA2, CHEK22, EPCAM3, HOXB13, MLH1, MSH2, MSH6 |
| Hereditary Colorectal Cancer (including Lynch syndrome) Panel | APC, BMPR1A, EPCAM3, MLH1, MSH2, MSH6, MUTYH, NTHL1, PMS24, POLD1, POLE, PTEN, SMAD4, STK11, TP53 |
| Hereditary Melanoma Cancer Panel | BAP1, BRCA2, CDK4, CDKN2A, PTEN |
| Hereditary Pancreatic Cancer Panel | APC, BRCA1, BRCA2, CDKN2A EPCAM3, MLH1, MSH2, MSH6, PALB2, STK11, TP53, VHL |